Display options
Share it on

Interdiscip Perspect Infect Dis. 2012;2012:463794. doi: 10.1155/2012/463794. Epub 2012 Aug 09.

Complement Attack against Aspergillus and Corresponding Evasion Mechanisms.

Interdisciplinary perspectives on infectious diseases

Cornelia Speth, Günter Rambach

Affiliations

  1. Division of Hygiene and Medical Microbiology, Innsbruck Medical University, Fritz-Pregl-Straße 3, 6020 Innsbruck, Austria.

PMID: 22927844 PMCID: PMC3423931 DOI: 10.1155/2012/463794

Abstract

Invasive aspergillosis shows a high mortality rate particularly in immunocompromised patients. Perpetually increasing numbers of affected patients highlight the importance of a clearer understanding of interactions between innate immunity and fungi. Innate immunity is considered to be the most significant host defence against invasive fungal infections. Complement represents a crucial part of this first line defence and comprises direct effects against invading pathogens as well as bridging functions to other parts of the immune network. However, despite the potency of complement to attack foreign pathogens, the prevalence of invasive fungal infections is increasing. Two possible reasons may explain that phenomenon: First, complement activation might be insufficient for an effective antifungal defence in risk patients (due to, e.g., low complement levels, poor recognition of fungal surface, or missing interplay with other immune elements in immunocompromised patients). On the other hand, fungi may have developed evasion strategies to avoid recognition and/or eradication by complement. In this review, we summarize the most important interactions between Aspergillus and the complement system. We describe the various ways of complement activation by Aspergillus and the antifungal effects of the system, and also show proven and probable mechanisms of Aspergillus for complement evasion.

References

  1. Clin Exp Allergy. 2000 Apr;30(4):476-84 - PubMed
  2. Mol Immunol. 2008 Mar;45(5):1485-93 - PubMed
  3. Clin Infect Dis. 1998 Apr;26(4):781-803; quiz 804-5 - PubMed
  4. Drugs. 2007;67(13):1803-12 - PubMed
  5. J Infect Dis. 2008 Feb 1;197(3):479-86 - PubMed
  6. J Biol Chem. 2009 Oct 9;284(41):28263-28275 - PubMed
  7. J Immunol. 2008 Nov 15;181(10):7100-5 - PubMed
  8. Blood. 2010 Dec 9;116(24):5170-80 - PubMed
  9. Immunopharmacology. 1997 Dec;38(1-2):3-15 - PubMed
  10. Immunobiology. 2007;212(4-5):245-52 - PubMed
  11. Mol Immunol. 2001 Aug;38(2-3):175-87 - PubMed
  12. J Immunol. 1999 Dec 1;163(11):6132-8 - PubMed
  13. CNS Drugs. 2007;21(8):659-76 - PubMed
  14. Microbes Infect. 2005 Oct;7(13):1285-95 - PubMed
  15. Contrib Microbiol. 2003;10:1-17 - PubMed
  16. Infect Immun. 1989 Nov;57(11):3412-7 - PubMed
  17. Med Microbiol Immunol. 1998 Oct;187(2):79-89 - PubMed
  18. Clin Immunol. 2006 Feb-Mar;118(2-3):127-36 - PubMed
  19. Immunity. 2008 Mar;28(3):425-35 - PubMed
  20. Int J Med Microbiol. 2011 Jun;301(5):436-44 - PubMed
  21. Mol Microbiol. 1997 Oct;26(1):175-83 - PubMed
  22. Microbes Infect. 2008 Nov-Dec;10(14-15):1567-76 - PubMed
  23. Nature. 1991 Feb 14;349(6310):614-7 - PubMed
  24. J Immunol. 2001 Mar 1;166(5):3410-5 - PubMed
  25. Autoimmun Rev. 2006 Feb;5(2):89-92 - PubMed
  26. Adv Drug Deliv Rev. 2011 Sep 16;63(12):965-75 - PubMed
  27. J Infect Dis. 2001 Sep 1;184(5):653-6 - PubMed
  28. Fungal Genet Biol. 2003 Mar;38(2):143-58 - PubMed
  29. J Infect Dis. 2011 Sep 1;204(5):802-9 - PubMed
  30. J Biol Chem. 2011 Mar 11;286(10):8021-8029 - PubMed
  31. Lab Invest. 2011 Jan;91(1):4-11 - PubMed
  32. J Bacteriol. 1998 Jun;180(12):3031-8 - PubMed
  33. Curr Opin Microbiol. 2010 Aug;13(4):409-15 - PubMed
  34. Immunol Res. 2006;36(1-3):197-210 - PubMed
  35. Med Mycol. 2005 May;43 Suppl 1:S207-38 - PubMed
  36. Int J Med Microbiol. 2002 Oct;292(5-6):405-19 - PubMed
  37. Glia. 2000 Apr;30(2):187-98 - PubMed
  38. Infect Immun. 2000 Jun;68(6):3736-9 - PubMed
  39. Am J Pathol. 2007 Sep;171(3):715-27 - PubMed
  40. Mol Immunol. 2004 Nov;41(11):1089-98 - PubMed
  41. Infect Immun. 1994 Apr;62(4):1192-8 - PubMed
  42. Infect Immun. 2005 Jan;73(1):494-503 - PubMed
  43. Infect Immun. 1990 May;58(5):1476-8 - PubMed
  44. Immunol Rev. 2000 Aug;176:194-204 - PubMed
  45. Front Microbiol. 2011 May 03;2:96 - PubMed
  46. Mol Immunol. 2010 Apr;47(7-8):1438-49 - PubMed
  47. Int J Immunogenet. 2009 Oct;36(5):289-99 - PubMed
  48. Clin Infect Dis. 2001 Feb 1;32(3):358-66 - PubMed
  49. Hum Pathol. 2002 Jan;33(1):116-24 - PubMed
  50. Brain Res Brain Res Rev. 1999 Jul;30(1):77-105 - PubMed
  51. Biochimie. 2008 Feb;90(2):387-95 - PubMed
  52. Infect Immun. 2000 Feb;68(2):688-93 - PubMed
  53. Neurology. 1985 Nov;35(11):1654-7 - PubMed
  54. J Infect Dis. 1992 Sep;166(3):580-6 - PubMed
  55. Infect Immun. 1985 May;48(2):458-63 - PubMed
  56. Ann N Y Acad Sci. 2003 May;992:56-71 - PubMed
  57. Infect Immun. 1990 Nov;58(11):3508-15 - PubMed
  58. Infect Immun. 2008 Feb;76(2):820-7 - PubMed
  59. Drugs. 2008;68(14):1941-62 - PubMed
  60. Immunol Rev. 2009 Jul;230(1):9-21 - PubMed
  61. J Immunol. 2012 Jan 1;188(1):21-8 - PubMed
  62. J Lab Clin Med. 1993 Jul;122(1):27-35 - PubMed
  63. Curr Opin Neurol. 2008 Jun;21(3):347-52 - PubMed
  64. Clin Exp Immunol. 2007 May;148(2):382-9 - PubMed
  65. Int Arch Allergy Appl Immunol. 1991;96(4):331-7 - PubMed
  66. Clin Microbiol Rev. 1996 Jan;9(1):34-46 - PubMed
  67. J Infect Dis. 1986 Dec;154(6):944-51 - PubMed
  68. BMC Microbiol. 2008 Dec 18;8:229 - PubMed
  69. Mol Immunol. 2011 Sep;48(15-16):2122-9 - PubMed
  70. Mol Immunol. 2002 May;38(12-13):947-57 - PubMed
  71. Infect Immun. 1992 May;60(5):1913-8 - PubMed
  72. Infect Immun. 2010 Aug;78(8):3585-94 - PubMed
  73. Immunology. 1990 Feb;69(2):237-42 - PubMed
  74. Mol Immunol. 2003 Nov;40(7):423-9 - PubMed
  75. Mycoses. 2008 Nov;51(6):477-96 - PubMed

Publication Types